type: misc

label: url

en: Molecular Mechanisms of Acute Radiation Intestinal Injury and Its Control

en: Radiation Environment and Medicine

ja: Radiation Environment and Medicine


en: Molecular mechanisms of acute radiation intestinal injury and its control

ja: 急性放射線腸管障害の分子機構とその制御

en: 放射線生物研究 = Radiation biology research communications : 放射線生物研究会機関誌


en: Japanese Translation of NCRP Statement No. 13 "NCRP Recommendations for Ending Routine Gonadal Shielding During Abdominal and Pelvic Radiography" and Its Accompanying Documents National Council on Radiation Protection and Measurements

ja: NCRP Statement No. 13「腹部・骨盤部単純X線撮影時の慣例的な生殖腺遮蔽の廃止に向けたNCRP勧告」とその付属文書National Council on Radiation Protection and Measurements

en: Japanese Journal of Health Physics

ja: 保健物理


en: Development of radioprotector based on the radiosensitivity modification by p53 regulation

ja: p53制御による放射線感受性修飾にもとづく防護剤開発

en: Radiation Biology Research Communications

ja: 放射線生物研究


en: Development of p53-targeting drugs that increase radioresistance in normal tissues.

en: Radiation damage to normal tissues is a serious concern in radiation therapy. Advances in radiotherapeutic technology have improved the dose distribution of the target volumes and risk organs, but damage to risk organs that are located within the irradiation field still limits the allowable prescription dose. To overcome this dose-limiting toxicity, and to further improve the efficacy of radiotherapy, the development of drugs that protect normal tissues but not cancer tissues from the effects of radiation are expected to be developed based on molecular target-based drugs. p53 is a well-known transcription factor that is closely associated with radiation-induced cell death. In radiation-injured tissues, p53 induces apoptosis in hematopoietic lineages, whereas it plays a radioprotective role in the gastrointestinal epithelium. These facts suggest that p53 inhibitor would be effective for radioprotection of the hematopoietic system, and that a drug that upregulates the radioprotective functions of p53 would enhance the radioresistance of gastrointestinal tissues. In this review, we summarize recent progress regarding the prevention of radiation injury by regulating p53 and provide new strategic insights into the development of radioprotectors in radiotherapy. J. Med. Invest. 66 : 219-223, August, 2019.

en: The Journal of Medical Investigation : JMI


en: 脳CT画像における死後変化と最近の研究動向

ja: 脳CT画像における死後変化と最近の研究動向

en: 日本診療放射線技師会雑誌

ja: 日本診療放射線技師会雑誌


en: Report on special sessions in the 49th Annual Meeting of the Japan Health Physics Society

ja: 第49回研究発表会における企画セッションの印象記

en: 保健物理


en: Study on Health Effects of Exposure to Radon : Recent Studies on Effects and Mechanisms of Radon Therapy.

ja: ラドンの健康影響に関する一考察 ラドン療法の効果と機構に関する最近の研究動向．

en: Transactions of the Atomic Energy Society of Japan

ja: 日本原子力学会和文論文誌


en: Recent Studies on Antinociceptive Effects of Radon Therapy for Pain-related Diseases

ja: ラドン療法に関する最近の研究動向-鎮痛効果に着目して-


en: NCRP Statement No. 13「腹部・骨盤部単純X線撮影時の慣例的な生殖腺遮蔽の廃止に向けたNCRP勧告」とその付属文書

misc_type: others


en: 極微量ウラン影響効果試験

ja: 極微量ウラン影響効果試験

en: JAEA-Research

ja: JAEA-Research